Amicus Therapeutics Inc. buy Wells Fargo & Company
Start price
20.02.25
/
50%
€8.70
Target price
20.02.26
€16.27
Performance (%)
39.08%
Price
08.01.26
€12.10
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Amicus Therapeutics Inc. has seen massive gains of 39.08%. This prediction currently runs until 20.02.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | 1.667% | 1.667% |
| iShares Core DAX® | 2.659% | 4.844% |
| iShares Nasdaq 100 | 0.916% | -0.554% |
| iShares Nikkei 225® | 2.426% | 1.598% |
| iShares S&P 500 | 1.230% | 1.039% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.90
30.05.24
30.05.24
€16.62
30.05.25
30.05.25
-39.89%
31.05.25
31.05.25
